(:NHLD)

Business Focus: N/A

Feb 25, 2021 03:01 pm ET

B. Riley Financial Completes Acquisition of National Holdings Corporation, Creates Meaningfully Enhanced Wealth Management Platform

LOS ANGELES and NEW YORK, Feb. 25, 2021 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley") and National Holdings Corporation (NASDAQ: NHLD) ("National") today announced the completion of the firms' previously announced merger. In connection with the transaction, National becomes a wholly owned subsidiary of B. Riley Financial and an affiliate of B. Riley Wealth Management. National adds nearly 700 registered representatives and assets of approximately $20 billion to the B. Riley Financial platform. B. Riley Wealth Management currently includes over 170 advisors and assets o

Feb 25, 2021 08:15 am ET

B. Riley Financial Announces Final Results of Cash Tender Offer for National Holdings Corporation

LOS ANGELES, Feb. 25, 2021 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley") today announced the successful completion and final results for the cash tender offer ("Offer") to purchase all the issued and outstanding shares of National Holdings Corporation (NASDAQ: NHLD) ("National") common stock ("Shares") not currently owned by B. Riley and its subsidiaries. The tender offer expired as scheduled at 12:00 midnight, New York City time, at the end of the day on February 24, 2021 and was not extended. B. Riley expects to complete the acquisition of National as soon as practic

Feb 23, 2021 08:31 am ET

Quantum Computing Inc. Appoints Robert B. Fagenson, National Holdings Vice Chairman and Former NYSE Floor Governor and Vice Chairman, to its Board of Directors

Quantum Computing Inc. (OTCQB: QUBT) (QCI), a leader in bridging the power of classical and quantum computing, has appointed finance and capital markets industry leader, Robert B. Fagenson, to serve on the company’s board of directors and as chair...

Feb 06, 2021 10:56 am ET

INVESTIGATION ALERT: Halper Sadeh LLP Investigates NHLD, FFG, CPAH, MDCA; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Feb. 6, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Feb 05, 2021 05:54 pm ET

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of NHLD, ALAC, SMTX, and DFHT Mergers

Rigrodsky Law, P.A. announces that it is investigating: National Holdings Corporation (NASDAQ CM: NHLD) regarding possible breaches of fiduciary duties and other violations of law related to National Holdings’ agreement to be acquired by B....

Feb 04, 2021 04:08 am ET

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, NHLD, COHR, UROV; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: MDC Partners Inc. (NASDAQ: MDCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to...

Feb 03, 2021 06:34 pm ET

Terra Income Fund 6, Inc. Prices Public Offering of $34.75 Million 7.00% Notes Due 2026

NEW YORK, Feb. 3, 2021 /PRNewswire/ -- Terra Income Fund 6, Inc. (the "Company") today announced that it has priced an underwritten public offering of $34.75 million in aggregate principal amount of 7.00% unsecured notes due 2026 (the "Notes"). The Notes will mature on March 31, 2026, and may be redeemed in whole or in part at any time or from time to time at the Company's option on or after February 10, 2023. The Notes will bear interest at a rate of 7.00% per year payable quarterly on March 30, June 30, September 30 and December 30 of each year, beginning June 30, 2021. The Company has gr

Feb 02, 2021 04:16 pm ET

Terra Income Fund 6, Inc. Announces Offering of Notes

NEW YORK, Feb. 2, 2021 /PRNewswire/ -- Terra Income Fund 6, Inc. (the "Company") announced the commencement of a registered public offering of Notes (the "Notes"). The Company expects to use the net proceeds from this offering to make investments in its targeted investments in accordance with its investment objectives and strategies and for general corporate purposes.

Feb 02, 2021 03:45 pm ET

SHAREHOLDER ALERT: WeissLaw LLP Reminds NHLD, MGLN, SMTX and FLIR Shareholders About Its Ongoing Investigations

NEW YORK, Feb. 2, 2021 /PRNewswire/ --

Jan 30, 2021 05:04 pm ET

Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - NHLD, COHR, MTSC, NK, PNM

NEW YORK, Jan. 30, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Jan 29, 2021 01:18 pm ET

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of NHLD, SSPK, PS, and TCF Mergers

Jan 28, 2021 03:05 pm ET

Crown Electrokinetics Announces Closing of $21.5 Million Public Offering Including Exercise of Overallotment Option

CORVALLIS, Ore., Jan. 28, 2021 /PRNewswire/ -- Crown Electrokinetics Corp. (NASDAQ: CRKN) ("Crown" or the "Company"), a leading smart glass technology company with a patented thin-film solution, today announced the closing of its previously announced underwritten public offering of 4,150,000 shares of its common stock at a public offering price of $4.50 per share. In addition, Crown granted the underwriters a 30-day over-allotment option to purchase up to an additional 622,500 shares of common stock at the public offering price, less underwriting discounts and commissions, of which the under

Jan 28, 2021 08:00 am ET

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates NHLD, COHR, ALSK, NK; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: National Holdings Corporation (NASDAQ: NHLD) concerning potential violations of the federal securities laws and/or breaches of fiduciary...

Jan 27, 2021 04:32 pm ET

B. Riley Financial Commences Tender Offer for All Outstanding Shares of National Holdings Corporation

LOS ANGELES, Jan. 27, 2021 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley"), a diversified financial services and business advisory company, through its wholly owned subsidiary ("Purchaser"), today commenced its previously announced cash tender offer to purchase the remaining outstanding shares of National Holdings Corporation (NASDAQ: NHLD) ("National") common stock ("Shares"), not currently owned by B. Riley and its subsidiares, for $3.25 per share, upon the terms and subject to the conditions set forth in the offer to purchase, dated January 27, 2021 (the "Offer to Pur

Jan 26, 2021 02:23 pm ET

SHAREHOLDER ALERT: WeissLaw LLP Reminds COHR, NHLD, MGLN, and SMTX Shareholders About Its Ongoing Investigations

NEW YORK, Jan. 26, 2021 /PRNewswire/ --

Jan 21, 2021 02:44 pm ET

MERGER INVESTIGATION: Halper Sadeh LLP Investigates NHLD, HMSY, PRGX; Shareholders Are Encouraged to Contact the Firm

Jan 20, 2021 11:15 am ET

INVESTIGATION ALERT: Halper Sadeh LLP Investigates FLIR, SMTX, NHLD, FFG, CMD; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 20, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Jan 19, 2021 02:47 pm ET

SHAREHOLDER ALERT: WeissLaw LLP Reminds NHLD, FFG, MGLN and SMTX Shareholders About Its Ongoing Investigations

NEW YORK, Jan. 19, 2021 /PRNewswire/ --

Jan 14, 2021 01:16 pm ET

INVESTIGATION ALERT: Halper Sadeh LLP Investigates RLH, FFG, NHLD, HCAP; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Red Lion Hotels Corporation (NYSE: RLH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties...

Jan 13, 2021 06:56 pm ET

NATIONAL HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of National Holdings Corporation - NHLD

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of National Holdings Corporation (NasdaqCM: NHLD) to B. Riley Financial, Inc. (NasdaqGS: RILY). Under the terms of the proposed transaction, shareholders of National Holdings will receive only $3.25 in cash for each share of National Holdings that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Jan 13, 2021 02:18 pm ET

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of National Holdings Corporation - NHLD

NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating National Holdings Corporation ("NHLD" or the "Company") (NHLD) relating to its proposed acquisition by B. Riley Financial, Inc. Under the terms of the tender offer, NHLD shareholders will receive $3.25 in cash per share they own.

Jan 13, 2021 11:54 am ET

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of National Holdings Corporation Buyout

Rigrodsky Law, P.A. announces that it is investigating National Holdings Corporation (“National Holdings”) (NASDAQ CM: NHLD) regarding possible breaches of fiduciary duties and other violations of law related to National Holdings’ agreement to be...

Jan 12, 2021 09:54 am ET

INVESTIGATION ALERT: Halper Sadeh LLP Investigates FFG, NHLD, HCAP, NAV, UROV; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Jan 11, 2021 03:31 pm ET

SHAREHOLDER ALERT: WeissLaw LLP Investigates National Holdings Corporation

NEW YORK, Jan. 11, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of National Holdings Corporation ("National Holdings" or the "Company") (NASDAQ: NHLD) in connection with the proposed interested-party acquisition of the Company by B. Riley Financial, Inc. ("B. Riley") (NASDAQ: RILY), a diversified financial services and business advisory company. The transaction is structured as an all-cash tender offer in which the Company's shareholders will receive $3.25 for each share of National Holdings comm

Jan 11, 2021 12:25 pm ET

NATIONAL HOLDINGS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of NHLD and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of National Holdings Corporation (NASDAQ: NHLD) breached their fiduciary duties or violated the federal...

Jan 11, 2021 09:39 am ET

National Holdings Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of National Holdings Corporation Is Fair to Shareholders; Investors Are Encouraged to Contact the

Halper Sadeh LLP, a global investor rights law firm, is investigating whether National Holdings Corporation (NASDAQ: NHLD) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of National Holdings to B. Riley Financial, Inc. for $3.25 per share.

Jan 11, 2021 06:30 am ET

B. Riley Financial to Acquire National Holdings

LOS ANGELES and NEW YORK, Jan. 11, 2021 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley"), a diversified financial services and business advisory company, has entered a definitive agreement to acquire National Holdings Corporation (NASDAQ: NHLD) ("National"), a full-service investment banking and asset management firm that, through its affiliates, provides a range of services including financial advisory, investment banking, institutional sales and trading, equity research, financial planning, market making, tax preparation and insurance to corporations, institutions, high

Dec 30, 2020 07:30 am ET

National Holdings Corporation Reports Financial Results for the 2020 Fiscal Fourth Quarter and 2020 Fiscal Year

National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service brokerage firm including employee-managed and independent branches, investment banking, trading, asset management and tax preparation, today...

Dec 22, 2020 05:00 pm ET

Seven Oaks Acquisition Corp. Announces Closing of Upsized $258.75 Million Initial Public Offering

Seven Oaks Acquisition Corp. (the “Company”) today announced the closing of its upsized initial public offering of 25,875,000 units at a price of $10.00 per unit, including 3,375,000 units issued pursuant to the exercise by the underwriters of...

Dec 22, 2020 08:00 am ET

SCYNEXIS Announces Closing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants and warrants. The shares and warrants were sold at a public offering price of $6.25 per share...

Dec 17, 2020 09:55 pm ET

Seven Oaks Acquisition Corp. Announces Pricing of Upsized $225 Million Initial Public Offering

Seven Oaks Acquisition Corp. (the “Company”) today announced the pricing of its upsized initial public offering of 22,500,000 units at a price of $10.00 per unit. The units will be listed on The NASDAQ Capital Market (“NASDAQ”) and trade under the...

Dec 17, 2020 09:28 am ET

SCYNEXIS Announces Pricing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the pricing of its underwritten public offering of common stock, pre-funded warrants and warrants. The shares and warrants are being sold at a public offering price of $6.25 per share and accompanying...

Dec 16, 2020 05:33 pm ET

Fidus Investment Corporation Prices Offering of $125 Million of 4.75% Notes Due 2026

Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that it priced a public offering of $125 million aggregate principal amount of 4.75% notes due 2026 (the “Notes”) on December 16, 2020. The Notes will mature on...

Dec 16, 2020 04:21 pm ET

SCYNEXIS Announces Launch of $50 Million Public Offering of Common Stock and Warrants

SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock, including pre-funded warrants to purchase common stock in lieu of...

Dec 15, 2020 05:18 pm ET

Vivos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Vivos Therapeutics, Inc. (“Vivos”) today announced the closing of its initial public offering of 4,025,000 shares of its common stock. The offering consisted of 3,500,000 shares of its common stock, as well as an additional 525,000 shares pursuant...

Dec 14, 2020 04:05 pm ET

AquaBounty Technologies, Inc. Announces Closing of $65.2 Million Upsized Public Offering of Common Stock, Including Full Exercise of Overallotment Option

AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the closing of its previously announced underwritten...

Dec 10, 2020 09:42 pm ET

Vivos Therapeutics Announces Pricing of $21M Initial Public Offering

Vivos Therapeutics, Inc. (“Vivos”), a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, today announced the pricing of its initial public offering of 3,500,000 shares of...

Dec 10, 2020 08:45 am ET

AquaBounty Technologies, Inc. Announces Pricing of $56.7 Million Upsized Public Offering of Common Stock

AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the pricing of its previously announced underwritten...

Dec 09, 2020 04:01 pm ET

AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock

AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that it has commenced a proposed underwritten public...

Nov 24, 2020 05:18 pm ET

Reed’s Inc. Announces Closing of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Reed’s Inc. (Nasdaq: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced it has closed its previously announced underwritten public offering of 18,750,000 shares and the full exercise of the...

Nov 20, 2020 08:27 am ET

Reed’s Inc. Prices Underwritten Public Offering of Common Stock

Reed’s Inc. (Nasdaq: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced the pricing of an underwritten public offering of 18,750,000 shares of its common stock at a price of $0.56 per share for...

Nov 19, 2020 04:46 pm ET

Reed’s Inc. Announces Proposed Public Offering of Common Stock

Reed’s Inc. (NASDAQ: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced that it intends to offer shares of its common stock in an underwritten public offering. Reed’s also expects to grant to the...

Oct 16, 2020 04:05 pm ET

Eton Pharmaceuticals Announces Closing of Public Offering

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced the closing of its previously announced offering of 3,220,000...

Oct 14, 2020 08:30 am ET

Eton Pharmaceuticals Prices Underwritten Public Offering of Common Stock

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced the pricing of an underwritten public offering of 2,800,000...

Oct 13, 2020 04:01 pm ET

Eton Pharmaceuticals Announces Proposed Public Offering of Common Stock

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that it is offering to sell shares of its common stock in an...

Oct 09, 2020 04:54 pm ET

Vivos Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering

via NetworkWire -- Vivos Therapeutics, Inc. (“Vivos”), a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, today announced that is has filed a registration statement on...

Sep 18, 2020 04:05 pm ET

Franchise Group, Inc. Closes Preferred Stock Offering

Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”) today announced the closing of its previously announced underwritten registered public offering of 1,200,000 shares of its 7.50% Series A Cumulative Perpetual Preferred Stock,...

Sep 15, 2020 07:52 am ET

Franchise Group, Inc. Announces Offering of Series A Cumulative Perpetual Preferred Stock

Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”) today announced it has commenced an underwritten registered public offering of shares of its Series A Cumulative Perpetual Preferred Stock, par value $0.01 per share and...

Aug 27, 2020 08:30 am ET

Super League Gaming Announces Pricing of $8.4 Million Underwritten Public Offering of Common Stock

Super League Gaming (Super League or the Company) (Nasdaq: SLGG), a global leader in competitive video gaming and esports entertainment for everyday players around the world, today announced the pricing of an underwritten public offering of...

Aug 20, 2020 04:05 pm ET

AquaBounty Technologies, Inc. Announces Full Exercise of Over-Allotment Option

Aug 13, 2020 04:01 pm ET

National Holdings Corporation Reports Financial Results, Including Record Revenue, for the Fiscal 2020 Third Quarter

National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading and asset management firm providing diverse services including tax preparation, today announced...

Aug 07, 2020 09:00 am ET

AquaBounty Technologies, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock

AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the pricing of its previously announced underwritten...

Aug 05, 2020 04:35 pm ET

Chicken Soup for the Soul Entertainment Announces the Partial Exercise of Underwriters’ Option to Purchase Additional Notes Due 2025

Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE) (the “Company”), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced that the underwriters of its recent public offering of...

Jul 17, 2020 04:35 pm ET

Chicken Soup for the Soul Entertainment Announces the Closing of $21 Million of Notes Due 2025

Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE) (the “Company”), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced the closing of its underwritten public offering of an...

Jul 13, 2020 09:00 am ET

Chicken Soup for the Soul Entertainment Announces Pricing of $21 Million of Notes Due 2025

Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE) (the “Company”), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced the pricing of its underwritten public offering of an...

Jun 22, 2020 04:05 pm ET

Catalyst Biosciences Announces Closing of Public Offering of Common Stock

Catalyst Biosciences, Inc. (NASDAQ:CBIO), today announced the closing of an underwritten public offering of 4,615,384 shares of its common stock, offered at a price of $6.50 per share to the public. The gross proceeds to Catalyst from this offering...

Jun 17, 2020 04:01 pm ET

Catalyst Biosciences Announces Proposed Public Offering of Common Stock

Catalyst Biosciences, Inc. (NASDAQ:CBIO) today announced that it is offering shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when...

May 19, 2020 04:01 pm ET

VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

AUSTIN, Texas, May 19, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Volition intends to grant the underwriters a 30-day option to purchase additional shares of its common stock sold in the offering, to cover overallotments, if any. All

May 15, 2020 01:04 pm ET

Atomera Announces Closing of Public Offering

Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today announced the closing of its previously announced...

May 15, 2020 08:00 am ET

National Holdings Corporation Reports Financial Results for the Fiscal 2020 Second Quarter

May 13, 2020 08:26 am ET

Atomera Incorporated Prices Underwritten Public Offering of Common Stock

May 12, 2020 04:05 pm ET

Atomera Incorporated Announces Proposed Public Offering of Common Stock

Apr 30, 2020 04:05 pm ET

NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

NeuBase Therapeutics, Inc. (Nasdaq: NBSE), a preclinical-stage biotechnology company focused on developing next generation therapies to treat rare genetic diseases caused by mutant genes, announced today the closing of its previously announced...

Apr 28, 2020 09:44 am ET

NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock

Apr 27, 2020 04:01 pm ET

NeuBase Therapeutics Announces Proposed Public Offering of Common Stock

Mar 24, 2020 05:10 pm ET

Eyenovia, Inc. Announces Closing of Approximately $6.0 Million Private Placement

Eyenovia, Inc. (NASDAQ:EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print technology, announced that today it closed its previously announced private...

Mar 23, 2020 06:35 pm ET

Eyenovia, Inc. Announces Approximately $6.0 Million Private Placement

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print technology, today announced that it has received subscriptions for a private...

Mar 23, 2020 04:30 pm ET

National Holdings Corporation Announces Change of Location of Annual Meeting of Stockholders to Be Held On April 2, 2020

National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”) today announced that, due to the emerging public health impact of the coronavirus pandemic, the location of the Company's 2020 annual meeting of stockholders has been...

Mar 05, 2020 09:00 am ET

National Holdings Corporation Selects CAIS to Expand Alternative Investment Access and Education

CAIS, the leading financial technology platform connecting financial advisors with alternative investments, today announced a new strategic partnership with National Holdings Corporation (NASDAQ: NHLD). National Holdings Corporation, or National, is a leading full-service independent brokerage, investment banking, trading, and asset

Feb 14, 2020 04:30 pm ET

National Holdings Corporation Reports Financial Results for the Fiscal First Quarter 2020

National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, tax and asset management firm, today announced its financial results for the fiscal first quarter of 2020....

Feb 06, 2020 08:00 am ET

Oxford Lane Capital Corp. Prices Preferred Stock Offering

Oxford Lane Capital Corp. (the “Company”) (Nasdaq GS: OXLC, OXLCO and OXLCM) today announced that it has priced an underwritten public offering of 3,500,000 shares of its newly designated 6.25% Series 2027 Term Preferred Shares (the “Preferred...

Feb 04, 2020 04:01 pm ET

Oxford Lane Capital Corp. Announces Preferred Stock Offering

Oxford Lane Capital Corp. (the “Company”) (NasdaqGS: OXLC, OXLCO and OXLCM) today announced that it plans to offer shares of its newly designated Series 2027 Term Preferred Shares (the “Preferred Stock”) in an underwritten public offering. The...

Jan 23, 2020 05:16 pm ET

ARMOUR Residential REIT, Inc. Prices $75 Million Public Offering of 7.00% Series C Cumulative Redeemable Preferred Stock

ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR‑PB) (“ARMOUR” or the “Company”) today announced the pricing of its underwritten registered public offering of 3 million shares of its new 7.00% Series C Cumulative Redeemable Preferred Stock (the...

Jan 06, 2020 07:30 am ET

National Holdings Corporation Announces Closing of Acquisition of Full-Service Investment Firm Winslow, Evans & Crocker, Inc.

National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking and asset management firm providing a wide array of services, announced the closing, on December 31, 2019,...

Dec 31, 2019 07:30 am ET

National Holdings Corporation Reports Financial Results for the 2019 Fiscal Fourth Quarter and 2019 Fiscal Year

Nov 20, 2019 09:20 am ET

Checkpoint Therapeutics Announces Pricing of Public Offering of Common Stock

Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the pricing of its previously announced underwritten public offering. Checkpoint is offering 13,400,000...

Nov 19, 2019 04:01 pm ET

Checkpoint Therapeutics Announces Proposed Public Offering of Common Stock

Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an...

Oct 23, 2019 12:28 pm ET

Fidus Investment Corporation Announces Exercise and Closing of Underwriters’ Overallotment Option to Purchase Additional 5.375% Notes Due 2024

Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that, in connection with its previously disclosed registered public offering of $55.0 million aggregate principal amount of its 5.375% notes due 2024 (the...

Oct 16, 2019 04:05 pm ET

Fidus Investment Corporation Announces Closing of Public Offering of $55,000,000 5.375% Notes Due 2024

Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that it has closed a registered public offering of $55.0 million aggregate principal amount of its 5.375% notes due 2024 (the “Notes”), which resulted in net...

Aug 26, 2019 04:05 pm ET

National Holdings Corporation to Acquire Full-Service Investment Firm Winslow, Evans & Crocker, Inc.

Aug 19, 2019 04:01 pm ET

National Holdings Corporation Adds Strategic New Hires to its Broker Dealer Subsidiary

National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a full-service independent brokerage, investment banking, insurance, accounting and asset management firm, today announced the addition of several strategic new hires to...

Aug 15, 2019 07:00 am ET

National Holdings Corporation Reports Financial Results for the Fiscal 2019 Third Quarter

Aug 08, 2019 09:13 am ET

National Holdings Corporation (Nasdaq: NHLD) to Ring The Nasdaq Stock Market Closing Bell

What: National Holdings Corporation (Nasdaq: NHLD), a full-service investment banking and asset management firm, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Michael Mullen, Chairman and Chief Executive...

Jul 17, 2019 04:44 pm ET

AzurRx BioPharma Announces Proposed Public Offering of Common Stock

AzurRx BioPharma (NASDAQ: AZRX), (“AzurRx” or the “Company”), announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. The Company expects to grant the underwriters a 30-day option to...

Jul 15, 2019 04:10 pm ET

Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners

Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), announced today that it has acquired assets and certain liabilities constituting the Biopharma Services business of Cancer Genetics, Inc. (NASDAQ: CGIX) (the...

Jun 20, 2019 09:20 am ET

Gladstone Land Corporation Announces Pricing of Common Stock Offering

Gladstone Land Corporation (Nasdaq: LAND) (the “Company”) today announced that it has priced its public offering of 2,000,000 shares of its common stock at a price to the public of $11.73 per share. The Company also granted the underwriters a...

Jun 14, 2019 04:05 pm ET

Mohawk Group Holdings, Inc. Closes Its Initial Public Offering

Mohawk Group Holdings, Inc. (NasdaqCM:MWK) (“Mohawk”) today announced the closing of its initial public offering of 3,600,000 shares of its common stock at a price of $10.00 per share. Mohawk received net proceeds from the offering of...

Jun 12, 2019 10:29 am ET

Mohawk Group Holdings, Inc. Announces Pricing of Initial Public Offering

Mohawk Group Holdings, Inc. (“Mohawk”) today announced the pricing of its initial public offering of 3,600,000 shares of its common stock, at a public offering price of $10.00 per share. Mohawk has granted the underwriters an option to purchase up...

May 29, 2019 08:01 am ET

Atomera Announces $6.7 Million Registered Direct Offering of Common Stock

Atomera Incorporated (Nasdaq: ATOM) today announced that it has entered into a definitive stock purchase agreement with institutional investors for the purchase of 1,675,000 shares of common stock, at an offering price of $4.00 per share, in a...

May 16, 2019 07:30 am ET

National Holdings Corporation Reports Financial Results for the Fiscal 2019 Second Quarter

May 10, 2019 09:00 am ET

Aqua Metals Prices $22 Million Public Offering of Common Stock

Aqua Metals, Inc. (Nasdaq: AQMS) today announced that it has priced its underwritten public offering of 11,000,000 shares of its common stock at a public offering price of $2.00 per share. Aqua Metals expects the gross proceeds from this offering...

May 09, 2019 04:25 pm ET

Aqua Metals Announces Proposed Public Offering of Common Stock

Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), which is reinventing lead recycling with its AquaRefining™ technology, today announced that it intends to offer and sell shares of its common stock in an underwritten public...

Apr 17, 2019 04:45 pm ET

AquaBounty Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares

AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a subsidiary of Intrexon Corporation (Nasdaq: XON), today announces the closing of...

Apr 04, 2019 09:55 pm ET

AquaBounty Technologies, Inc. Announces Pricing of $5.75 Million Public Offering of Common Stock

Mar 27, 2019 06:18 pm ET

Oxford Square Capital Corp. Prices Public Offering of $42.5 Million 6.25% Notes Due 2026

Oxford Square Capital Corp. (NasdaqGS: OXSQ) (the “Company”) today announced that it has priced an underwritten public offering of $42.5 million in aggregate principal amount of 6.25% unsecured notes due 2026. The notes will mature on April 30,...

Mar 21, 2019 04:01 pm ET

AquaBounty Technologies, Inc. Announces Closing of Public Offering of Common Stock

AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon Corporation (Nasdaq: XON), today announces...

Mar 19, 2019 06:00 am ET

AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock

Feb 20, 2019 06:00 am ET

National Holdings Corporation to Host Conference Call on Fiscal First Quarter 2019 Financial Results

Feb 15, 2019 07:30 am ET

National Holdings Corporation Reports Financial Results for the Fiscal First Quarter 2019

Feb 13, 2019 12:00 pm ET

National Holdings Announces Changes to its Board of Directors with Appointments of Two New Independent Directors

Feb 04, 2019 07:30 am ET

National Holdings Announces Addition of Arthur R. Hogan to Management Team as Managing Director, Chief Market Strategist

Jan 22, 2019 04:05 pm ET

Aqua Metals Announces Closing of Common Stock Offering and Exercise in Full of Underwriter’s Overallotment Option

Aqua Metals, Inc. (NASDAQ: AQMS), (“Aqua Metals” or the “Company”), which is commercializing its proprietary AquaRefining™ electrochemical lead recycling technology, today announced the closing of its previously announced offering of 5,175,000...

Jan 17, 2019 08:45 am ET

Aqua Metals Prices Public Offering of Common Stock

Aqua Metals, Inc. (NASDAQ: AQMS), (“Aqua Metals” or the “Company”), which is commercializing its proprietary AquaRefining™ electrochemical lead recycling technology, today announced the pricing of its previously announced underwritten public...

Jan 16, 2019 05:18 pm ET

Aqua Metals Announces Proposed Public Offering of Common Stock

Aqua Metals, Inc. (NASDAQ: AQMS), (“Aqua Metals” or the “Company”), which is commercializing its proprietary AquaRefining™ electrochemical lead recycling technology, today announced that it is proposing to offer and sell, subject to market...

Dec 21, 2018 04:00 pm ET

National Holdings Corporation Reports Record Financial Results for the 2018 Fiscal Year

Dec 19, 2018 09:05 am ET

Eyenovia Prices Public Offering of Common Stock

Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print technology, has priced its underwritten public...

Nov 19, 2018 08:00 am ET

B. Riley Financial Enters a Definitive Agreement to Purchase Fortress Biotech’s Stake in National Holdings Corporation

National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full-service independent brokerage, investment banking, trading, insurance, accounting and asset management firm, today announced that B. Riley Financial, Inc....

Nov 19, 2018 08:00 am ET

B. Riley Financial Enters Agreement to Purchase Fortress Biotech’s Stake in National Holdings

B. Riley Financial, Inc. (NASDAQ: RILY) today announced its wholly owned subsidiary has entered into an agreement to acquire Fortress Biotech, Inc.’s (NASDAQ: FBIO) majority stake in National Holdings Corporation (NASDAQ: NHLD) for an aggregate...

Nov 19, 2018 08:00 am ET

Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial

Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that it has entered into an agreement to sell...

Nov 15, 2018 08:13 pm ET

Valeritas Announces Pricing of $36 Million Public Offering

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced the pricing of its...

Nov 12, 2018 04:52 pm ET

Eton Pharmaceuticals Announces Pricing of Initial Public Offering

Eton Pharmaceuticals, Inc (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced the pricing of its initial public offering of 3,600,000 shares of its common stock at a...

Oct 15, 2018 04:03 pm ET

Atomera Announces Closing of Public Offering of Common Stock

Atomera Incorporated (Nasdaq: ATOM) today announced the closing of its previously announced underwritten public offering of 2,625,000 shares of common stock at a public offering price of $4.75 per share. Atomera has also granted the underwriters a...

Oct 10, 2018 04:05 pm ET

Atomera Announces Proposed Public Offering of Common Stock

Atomera Incorporated (Nasdaq: ATOM) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Atomera also expects to grant the underwriters a 30-day option to purchase additional shares of...

Sep 27, 2018 07:30 am ET

National Announces Expansion of Equity Research Team

Aug 22, 2018 04:30 pm ET

Gladstone Investment Corporation Announces Closing of Offering of 2,990,000 Shares of its 6.375% Series E Cumulative Term Preferred Stock for Gross Proceeds of Approximately $74.8 million

Gladstone Investment Corporation (Nasdaq: GAIN) (the “Company”) today announced that it closed its previously announced offering of 2,600,000 shares of its newly-designated 6.375% Series E Cumulative Term Preferred Stock due 2025 (the “Series E...

Aug 20, 2018 07:33 am ET

National Holdings Corporation Announces Expansion of Capital Markets Team

National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full-service independent brokerage, investment banking, trading insurance accounting and asset management firm, today announced the expansion of its Capital...

Aug 16, 2018 04:05 pm ET

Restoration Robotics, Inc™ Announces Full Exercise and Closing of Underwriters’ Over-allotment Option

Restoration Robotics™, Inc. (NASDAQ: HAIR), the global leader in robotic hair restoration, today announced that the underwriters of Restoration Robotics’ previously announced public offering that closed on August 14, 2018, have purchased an...

Aug 15, 2018 09:00 am ET

Gladstone Investment Corporation Prices Series E Term Preferred Stock Offering

Gladstone Investment Corporation (NASDAQ: GAIN) (the “Company”) today announced that it has entered into an agreement to sell 2,600,000 shares of its newly designated 6.375% Series E Cumulative Term Preferred Stock due 2025 (the “Series E Term...

Aug 14, 2018 09:00 am ET

Gladstone Investment Corporation Launches New Series E Term Preferred Stock Offering

Gladstone Investment Corporation (NASDAQ: GAIN) (the “Company”) today announced that it plans to sell shares of its newly designated Series E Cumulative Term Preferred Stock due 2025 (the “Series E Term Preferred Stock”) in an underwritten public...

Aug 14, 2018 07:30 am ET

National Holdings Corporation Reports Financial Results for the Fiscal Third Quarter 2018

National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading, insurance, accounting and asset management firm providing diverse services including tax...

Aug 09, 2018 09:53 pm ET

Restoration Robotics™ Announces Pricing of Public Offering of Common Stock

Restoration Robotics™, Inc. (NASDAQ: HAIR) today announced the pricing of its public offering of 10,000,000 shares of common stock at a public offering price of $1.50 per share, before the underwriting discount. All of the shares of common stock...

Aug 08, 2018 04:01 pm ET

Workhorse Group Announces Proposed Public Offering of its Common Stock

CINCINNATI, Aug. 8, 2018 /PRNewswire/ -- Workhorse Group Inc. (NASDAQ: WKHS) ("Workhorse" or "the Company"), an American technology company focused on providing sustainable and cost-effective electric mobility solutions to the transportation sector, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. Workhorse expects to grant the underwriter a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any. All of th

Jul 24, 2018 03:24 pm ET

Manhattan Bridge Capital Announces Closing of Public Offering of Common Shares

Manhattan Bridge Capital, Inc. (Nasdaq:LOAN), or Manhattan Bridge Capital, a real estate finance company specializing in originating, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real estate,...

Jul 23, 2018 07:30 am ET

National Holdings Appoints Henry E. Kaplan as President and Chief Operating Officer of National Asset Management

National Holdings Corporation (NASDAQ:NHLD) (“National” or the “Company”), a leading full-service independent brokerage, investment banking, trading, insurance, accounting and asset management firm, today announced the appointment of Henry E....

Jul 20, 2018 12:40 pm ET

National Holdings Corporation Announces Round of Executive Promotions

National Holdings Corporation (NASDAQ:NHLD) (“National” or the “Company”), a leading full-service independent brokerage, investment banking, trading, insurance, accounting and asset management firm, today announced the following executive...

Jul 20, 2018 08:45 am ET

Manhattan Bridge Capital Announces Pricing of Public Offering of Common Shares

Jul 19, 2018 04:01 pm ET

Manhattan Bridge Capital Announces Proposed Public Offering of Common Shares

Jun 18, 2018 04:10 pm ET

Aqua Metals Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Overallotment Option

Aqua Metals, Inc. (Nasdaq:AQMS), (“Aqua Metals” or the “Company”), today announced that it has closed its previously-announced public offering of 10.1 million shares of its common stock at a price to the public of $2.85 per share, for gross...

Jun 14, 2018 09:10 am ET

Aqua Metals Prices $25 Million Public Offering of Common Stock

Aqua Metals, Inc. (Nasdaq:AQMS), (“Aqua Metals” or the “Company”), today announced that it has priced its underwritten public offering of 8,770,000 shares of its common stock at a public offering price of $2.85 per share. Aqua Metals expects the...

Jun 12, 2018 09:00 am ET

National Holdings Announces Strategic Reorganization of Board of Directors and Expansion of Senior Management

National Holdings Corporation (NASDAQ:NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading and asset management firm providing diverse services including tax preparation, today announced a...

May 15, 2018 07:40 am ET

National Holdings Corporation Reports Financial Results for the Fiscal Second Quarter 2018

National Holdings Corporation (NASDAQ:NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading and asset management firm providing diverse services including tax preparation, today announced its...

Apr 26, 2018 05:30 pm ET

Marrone Bio Innovations Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

DAVIS, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI or the “Company”), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today...

Apr 20, 2018 12:45 pm ET

Marrone Bio Innovations Announces Closing of $12 Million Public Offering of Common Stock

DAVIS, Calif., April 20, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI or the “Company”), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, announced...

Apr 18, 2018 08:45 am ET

Marrone Bio Innovations, Inc. Announces Pricing of Its Common Stock Offering

DAVIS, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (or "the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today...

Apr 17, 2018 04:30 pm ET

Marrone Bio Innovations, Inc. Announces Proposed Public Offering of Common Stock

DAVIS, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) or ("the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today...

Apr 16, 2018 07:00 am ET

Stemline Therapeutics Expands Board of Directors; Further Enhances Commercial Expertise with Appointment of Darren Cline

NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced expansion of its Board of Directors to include members with expertise in commercial, legal and finance.

Apr 03, 2018 06:00 am ET

Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform

AUSTIN, Texas, April 3, 2018 /PRNewswire/ -- TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and conditions, announced it has closed an offering of Series A preferred stock for gross proceeds of $14 million. The offering will be used to accelerate development of the Company's pipeline of advanced performance dry powder drugs for the treatment of pulmonary diseases and conditions such as lung transplant, severe asthma, COPD, and pulmonary infections.

Mar 27, 2018 04:01 pm ET

Gladstone Land Corporation Announces Pricing of Common Stock Offering

MCLEAN, Va., March 27, 2018 (GLOBE NEWSWIRE) -- Gladstone Land Corporation (Nasdaq:LAND) (the “Company”) today announced that it has priced its public offering of 1,100,000 shares of its common stock at a price to the public of $12.15...

Mar 13, 2018 04:05 pm ET

VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock

ISNES, Belgium, March 13, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers, announced today the closing of its previously announced underwritten public offering of 3,500,000 shares of common stock at a public offering price of $2.40 per share for gross proceeds of $8.4 million, before deducting underwriting discounts, commissions and estimated offering expenses payable by Volition. All of the shares of common st

Mar 09, 2018 08:10 am ET

VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock

ISNES, Belgium, March 9, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers, announced today the pricing of its previously announced underwritten public offering of 3,500,000 shares of common stock at a public offering price of $2.40 per share. The gross proceeds to Volition from this offering are expected to be approximately $8.4 million, before deducting underwriting discounts and commissions and other estimated o

Mar 08, 2018 03:01 pm ET

VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

NAMUR, Belgium, March 8, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Volition intends to grant the underwriters a 30-day option to purchase additional shares of its common stock sold in the offering, to cover overallotments, if any. All shares of common stock in the offering are being offered by

Mar 08, 2018 09:00 am ET

Checkpoint Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (Nasdaq:CKPT), a Fortress Biotech (Nasdaq:FBIO) company, today announced the pricing of its previously announced underwritten public offering. Checkpoint is offering 4,600,000 shares of...

Mar 07, 2018 04:05 pm ET

Checkpoint Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (Nasdaq:CKPT), a Fortress Biotech (Nasdaq:FBIO) company, today announced that it is proposing to offer and sell, subject to market conditions, shares of its...

Feb 27, 2018 03:05 pm ET

ClearSign Combustion Corporation Closes $12.94 M Public Offering of Common Stock

SEATTLE, Feb. 27, 2018 /PRNewswire/ -- ClearSign Combustion Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion technologies that reduce emissions and improve efficiency, today announced the closing of its previously announced underwritten public offering of 5,000,000 shares of common stock at a price of $2.25 per share. In addition, the underwriter exercised the over-allotment option to purchase 750,000 additional shares of common stock at the public offering price. All of the common stock was offered by the Company.

Feb 23, 2018 07:45 am ET

ClearSign Combustion Corporation Announces Pricing Of Public Offering Of Common Stock

SEATTLE, Feb. 23, 2018 /PRNewswire/ -- ClearSign Combustion Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion technologies that reduce emissions and improve efficiency, today announced the pricing of its previously announced underwritten public offering. ClearSign is offering 5,000,000 shares of its common stock, par value $0.0001 per share, at a price to the public of $2.25 per share. In connection with the offering, ClearSign has also granted the underwriter a 45-day option to purchase up to an additional 750,000 shares of common stock o

Feb 22, 2018 03:11 pm ET

ClearSign Combustion Corporation Announces Proposed Public Offering of Common Stock

SEATTLE, Feb. 22, 2018 /PRNewswire/ -- ClearSign Combustion Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion technologies that reduce emissions and improve efficiency, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. ClearSign expects to grant the underwriter a 45-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any. All of the common stock is bei

Feb 14, 2018 04:30 pm ET

National Holdings Corporation Reports Financial Results for the Fiscal 2018 First Quarter

NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- National Holdings Corporation (NASDAQ:NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading and asset management firm providing diverse services including tax preparation, today announced its...

Feb 06, 2018 08:30 am ET

Marrone Bio Innovations, Inc. Announces Closing of Private Placement and Debt Refinancing Transactions

Proceeds Provide Resources to Execute Upon Business Strategy

Feb 06, 2018 07:30 am ET

National Securities Corporation Successfully Arranges $75,000,000 Private Placement and Debt Refinancing for Marrone Bio Innovations, Inc.

NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NASDAQ:NHLD), a leading full service independent brokerage, investment banking and asset management firm, recently acted as the exclusive placement...

Feb 01, 2018 05:07 pm ET

Marrone Bio Innovations, Inc. Announces Stockholder Approval of Private Placement and Debt Refinance Transactions

Appoints Two New Board Members; Bob Woods as Chairman and Yogesh Mago

Jan 23, 2018 06:28 pm ET

Spark Energy, Inc. Announces Pricing of Series A Preferred Stock

HOUSTON, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Spark Energy, Inc. (“Spark” or the “Company”) (NASDAQ:SPKE), an independent retail energy services company, announced the pricing of a public offering of 2,000,000 shares of its 8.75% Series A Fixed-to-Floating Rate...

Jan 23, 2018 09:00 am ET

Spark Energy, Inc. Announces Public Offering of Series A Preferred Stock

HOUSTON, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Spark Energy, Inc. (“Spark” or the “Company”) (NASDAQ:SPKE), an independent retail energy services company, announced today that it has commenced a public offering of its 8.75% Series A Fixed-to-Floating Rate Cumulative...

Jan 18, 2018 05:54 am ET

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating National Holdings Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, Jan. 18, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of National Holdings Corporation (NASDAQ: NHLD).

Dec 22, 2017 04:30 pm ET

National Holdings Corporation Reports Financial Results for the 2017 Fiscal Year

NEW YORK, Dec. 22, 2017 (GLOBE NEWSWIRE) -- National Holdings Corporation (NASDAQ:NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading and asset management firm providing diverse services including tax preparation, today announced its...

Dec 18, 2017 07:00 am ET

Marrone Bio Innovations, Inc. Announces Comprehensive Financing and Debt Restructuring Transaction

$30 Million Private Placement of Common Stock and Warrants Concurrent Conversion of $45 Million of Outstanding Debt into Equity

Nov 28, 2017 07:30 am ET

National Holdings Corporation Announces Key Additions to Management Team

NEW YORK, Nov. 28, 2017 (GLOBE NEWSWIRE) -- National Holdings Corporation (NASDAQ:NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading and asset management firm providing diverse services including tax preparation, today announced the...

Nov 28, 2017 06:50 am ET

ReWalk Robotics Announces Full Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares in Follow-on Public Offering

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or the “Company”) today announced that National Securities Corporation (“National”), the underwriter of ReWalk’s underwritten public offering of ordinary shares, exercised in full...

Nov 17, 2017 06:50 am ET

ReWalk Robotics Announces Pricing of Follow-on Public Offering of Ordinary Shares

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or the “Company”) today announced that it has priced its underwritten public offering of 6,857,000 ordinary shares at a price to...

Nov 07, 2017 08:30 am ET

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that it has priced an underwritten public offering of...

Nov 01, 2017 09:20 am ET

Fortress Biotech Announces Proposed Public Offering of Series A Preferred Stock

NEW YORK, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that it intends to offer and sell shares of...

Sep 26, 2017 07:30 am ET

Resonant Inc. Announces Signing of Securities Purchase Agreement to Raise Up to $9.3 Million in Gross Proceeds

Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced it has entered into a definitive agreement with various...

Jul 12, 2017 05:53 pm ET

Air Industries Group Announces Closing of Public Offering

HAUPPAUGE, N.Y., July 12, 2017 (GLOBE NEWSWIRE) -- Air Industries Group (NYSE MKT:AIRI) (“Air Industries” or the “Company”), an integrated manufacturer of precision equipment assemblies and components for leading aerospace and defense prime contractors, today announced the closing of its previously announced public offering of common stock. Air Industries sold to the underwriters 5,175,000 shares of common stock, including 675,000 shares upon the exercise in full of the over-allotment option granted to the underwriters, at a public offering price of $1.50 per share....

Jul 07, 2017 09:08 am ET

Air Industries Group Announces Pricing of Its Common Stock

HAUPPAUGE, N.Y., July 07, 2017 (GLOBE NEWSWIRE) -- Air Industries Group (NYSE MKT:AIRI) (“Air Industries” or the “Company”), an integrated manufacturer of precision equipment assemblies and components for leading aerospace and defense prime contractors, today announced the pricing of an underwritten public offering of 4,500,000 newly issued shares of its common stock at a price to the public of $1.50 per share. The gross proceeds to Air Industries from this offering are expected to be approximately $6.75 million, before deducting underwriting discounts and commissions and other offering expe...

Jun 26, 2017 07:30 pm ET

Avenue Therapeutics Prices Initial Public Offering of $33,000,000 of Common Stock

NEW YORK, June 26, 2017 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech, Inc. (NASDAQ:FBIO) company, announced today the pricing of its initial public offering of 5,500,000 shares of common stock at an initial public offering price of $6.00 per share. The gross proceeds to Avenue from the initial public offering are expected to be $33,000,000, before underwriting discounts and commissions and other estimated offering expenses. Avenue has granted the underwriters a 30-day option to purchase up to 825,000 additional shares of common stock, which may be purchased so...

Jun 07, 2017 08:00 am ET

Oxford Lane Capital Corp. Prices Preferred Stock Offering

Oxford Lane Capital Corp. (the "Company") (NASDAQ: OXLC) (NASDAQ: OXLCO) (NASDAQ: OXLCN) today announced that it has priced an underwritten public offering of 2,500,000 shares of its newly designated 6.75% Series 2024 Term Preferred Shares (the "Preferred Stock") at a public offering price of $25 per share, raising $62.5 million in gross proceeds. The Company has also granted the underwriters a 30-day option to purchase up to 375,000 additional shares of Preferred Stock on the same terms and conditions to cover over-allotments, if any. The closing of the transaction is subject to customary

Jun 05, 2017 04:15 pm ET

Oxford Lane Capital Corp. Announces Preferred Stock Offering

Oxford Lane Capital Corp. (the "Company") (NASDAQ: OXLC) (NASDAQ: OXLCO) (NASDAQ: OXLCN) today announced that it plans to offer shares of its newly designated Series 2024 Term Preferred Shares (the "Preferred Stock") in an underwritten public offering. The public offering price and other terms of the Preferred Stock are to be determined by negotiations between the Company and the underwriters. The Company also plans to grant the underwriters a 30-day option to purchase additional shares of Preferred Stock on the same terms and conditions to cover over-allotments, if any.

May 09, 2017 09:00 am ET

ENDRA Life Sciences Inc. Prices Initial Public Offering

ANN ARBOR, Mich., May 9, 2017 /PRNewswire/ -- ENDRA Life Sciences Inc. ("ENDRA" or the "Company") (NASDAQ: NDRAU), a developer of photo- and thermo-acoustic technology to bring new capabilities to existing ultrasound systems, today announced the pricing of its initial public offering of 1,680,000 units, each consisting of one share of common stock and a warrant to purchase one share of common stock, at an offering price of $5.00 per unit. The common stock and warrants will trade together as units during the first 60 days following the date of the prospectus pursuant to which the offering is

Apr 12, 2017 11:58 am ET

TICC Capital Corp. Completes Public Offering of $64,370,225 6.50% Notes Due 2024

TICC Capital Corp. (NASDAQ: TICC) (the "Company") today announced that it has completed an underwritten public offering of $64,370,225 in aggregate principal amount of 6.50% unsecured notes due 2024, which includes the partial exercise of $6,870,225 of the underwriters' option to purchase up to an additional $8,625,000 in aggregate principal amount of notes. The notes will mature on March 30, 2024, and may be redeemed in whole or in part at any time or from time to time at the Company's option on or after March 30, 2020. The notes will bear interest at a rate of 6.50% per year payable

Apr 11, 2017 10:57 am ET

Rare Opportunities exposed widow to substantial losses - Claim Alleges

FT. LAUDERDALE, Fla., April 11, 2017 /PRNewswire/ -- The law firm of Securities Fraud Attorney Mark A. Tepper has filed claim against National Securities Corporation, a subsidiary of National Holdings Corporation (NASDAQ: NHLD), on behalf of a retired widow. The claim seeks recovery of substantial losses suffered by the widow from the broker's rare opportunities.

Apr 04, 2017 05:28 pm ET

TICC Capital Corp. Prices Public Offering of $57.5 Million 6.50% Notes Due 2024

TICC Capital Corp. (NASDAQ: TICC) (the "Company") today announced that it has priced an underwritten public offering of $57.5 million in aggregate principal amount of 6.50% unsecured notes due 2024. The notes will mature on March 30, 2024, and may be redeemed in whole or in part at any time or from time to time at the Company's option on or after March 30, 2020. The notes will bear interest at a rate of 6.50% per year payable quarterly on March 30, June 30, September 30, and December 30 of each year, commencing June 30, 2017.

Apr 03, 2017 04:23 pm ET

TICC Capital Corp. Announces Offering of Notes

TICC Capital Corp. (NASDAQ: TICC) (the "Company") announced the commencement of a registered public offering of Notes (the "Notes").

Mar 29, 2017 04:01 pm ET

Vital Therapies Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

SAN DIEGO, March 29, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced that in connection with its previously disclosed underwritten public offering, the underwriters have exercised in full their option to purchase an additional 1,312,500 shares of its common stock. Including this option exercise, the total gross proceeds from the offering of an aggregate of 10,062,500 shares at a price to the public of $4.00 per share will be approximately $4...

Mar 22, 2017 09:00 am ET

Imprimis Pharmaceuticals to Raise $3.1 Million in Registered Direct Offering

SAN DIEGO, March 22, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, announced today that it has entered into agreements with two accredited investors for a registered direct placement of 1,312,000 shares of common stock at a price of $2.40 per share for aggregate gross proceeds of $3,148,800. The offering is expected to close on or about March 27, 2017, subject to satisfaction of customary closing conditions.

Mar 21, 2017 04:01 pm ET

Vital Therapies Announces Proposed Public Offering of Common Stock

SAN DIEGO, March 21, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing the ELAD® System, a cell-based therapy targeting the treatment of liver failure, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. In addition, Vital Therapies expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the number of shares of common stock offered in the public offering at the public offering price, less the underwriting discounts and commissions. The ...

Mar 16, 2017 04:05 pm ET

Fortress Biotech Reports Financial Results for the Fourth Quarter and Full Year Ended December 31, 2016

NEW YORK, March 16, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced financial results and recent corporate highlights for the fourth quarter and full year ended December 31, 2016....

Feb 28, 2017 08:00 am ET

Checkpoint Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lung Cancer Compound CK-101

NEW YORK, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that the U.S. Patent and Trademark Office has issued a composition of matter patent for CK-101 (also known as RX518), Checkpoint’s oral, third-generation epidermal growth factor receptor (EGFR) inhibitor product candidate under development for the treatment of patients with EGFR mutation-positive non-small cell lung cancer (NSCLC)....

Feb 27, 2017 04:01 pm ET

Ideal Power Announces $15 Million Private Placement

Ideal Power Inc. (NASDAQ: IPWR), a developer of innovative power conversion technologies, has entered into a definitive securities purchase agreement with various accredited investors, including all of Ideal Power's executive officers and directors, to raise gross proceeds of approximately $15 million in a private placement of common stock and warrants to purchase common stock. In addition, Ideal Power has agreed to sell to a group of affiliated investors whose purchase of common stock would have resulted in such investors beneficially owning more than 9.99% of the Company's outstanding

Feb 15, 2017 09:00 am ET

National Holdings Corporation Reports Fiscal First Quarter 2017 Results

NEW YORK, Feb. 15, 2017 (GLOBE NEWSWIRE) -- National Holdings Corporation (NASDAQ:NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking and asset management firm providing diverse services including tax preparation, today announced its financial results for the fiscal first quarter 2017 ended December 31, 2016....

Feb 02, 2017 07:30 am ET

Fortress Biotech Announces that its Subsidiary, Mustang Bio, Closes $94.5 Million Private Placement Financing

NEW YORK, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that Mustang Bio, Inc. (“Mustang”), a subsidiary of Fortress, has closed on a total of $94.5 million, prior to fees and expenses, in a private placement financing. OPN Capital Markets, the healthcare related investment banking and research division of National Securities Corporation, a wholly owned subsidiary of National Holdings Corporation (NASDAQ:N...

Feb 02, 2017 07:30 am ET

National Holdings’ OPN Capital Markets Closes $94.5 Million Private Placement Financing for Mustang Bio, Inc., a Subsidiary of Fortress Biotech

NEW YORK, Feb. 02, 2017 (GLOBE NEWSWIRE) -- OPN Capital Markets, the healthcare related investment banking and research division of National Securities Corporation, a wholly owned subsidiary of National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"), a full-service investment banking and asset management firm, today announced the successful completion of a private raise of $94.5 million for Mustang Bio, Inc., a subsidiary of Fortress Biotech, Inc. (NASDAQ:FBIO). ...

Dec 28, 2016 05:00 pm ET

Fortress Biotech Announces Publication on MB‐101 (IL13Rα2‐specific CAR T cells) for the Treatment of Glioblastoma in New England Journal of Medicine

MB-101 is lead development candidate of Mustang Bio, a Fortress Company...

Dec 19, 2016 04:30 pm ET

Imprimis Pharmaceuticals Announces $9.8 Million Private Placement of Units

SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today announced that it has entered into a definitive securities purchase agreement with various accredited investors and certain members of Imprimis' Board of Directors and senior management, including the CEO, CFO, and Senior Director of Corporate Development, to raise gross proceeds of approximately $9.8 million in a private placement of Units.

Dec 13, 2016 08:30 am ET

National Holdings Corporation Responds to Inquiries Regarding Warrant Record, Ex-Dividend and Issuance Dates

NEW YORK, Dec. 13, 2016 (GLOBE NEWSWIRE) -- As previously announced on October 26, 2016, National Holdings Corporation (NASDAQ:NHLD) (“National Holdings” or the “Company”), a full-service investment banking and asset management firm, established December 9, 2016 as the record date for the distribution as a dividend of warrants to purchase shares of the Company’s common stock. The distribution of the warrants was contemplated by the Agreement and Plan of Merger dated as of April 27, 2016 by and among National Holdings, Fortress Biotech, Inc. and FBIO Acquisition, Inc....

Nov 15, 2016 04:57 pm ET

Aqua Metals Announces Proposed Public Offering of Common Stock

ALAMEDA, Calif., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Aqua Metals (NASDAQ:AQMS), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining™, today announced that it is offering to sell shares of its common stock in an underwritten public offering. The company expects to price the offering on or about Wednesday, November 16, 2016....

Nov 09, 2016 04:05 pm ET

Fortress Biotech Reports Third Quarter 2016 Financial Results and Recent Corporate Highlights

NEW YORK, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced its financial results and recent corporate highlights for the quarter ended September 30, 2016....

Nov 07, 2016 08:00 am ET

Fortress Biotech Forms New Subsidiary, Cellvation, Inc., to Develop Novel Therapies for the Treatment of Traumatic Brain Injury

Cellvation to Advance Three Programs Licensed from UTHealth...

Nov 07, 2016 08:00 am ET

フォートレス･バイオテック、外傷性脳損傷の新たな治療法を開発するため、子会社セルヴェーション･インクを新設

セルヴェーションはＵＴヘルスからライセンスを取得、3つのプログラムを前進させる...

Oct 26, 2016 07:30 am ET

National Holdings’ National Securities Corporation Rebrands its Healthcare Business as OPN Capital Markets

NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) -- National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"), a full-service investment banking and asset management firm, today announced that the Company’s healthcare related investment banking and research businesses will operate under the name OPN Capital Market....

Oct 13, 2016 04:00 am ET

Nano Dimension Ltd. Announces Exercise of Over-Allotment Option by Underwriters

NESS ZIONA, Israel, Oct. 13, 2016 /PRNewswire/ -- Nano Dimension Ltd, a leader in the field of 3D Printed Electronics (NASDAQ, TASE: NNDM), today announced that the underwriters of its previously announced public offering of 1,850,000 American Depository Shares (ADSs) have exercised their option to purchase an additional 275,275 ADSs, at $6.50 per ADS to cover over allotments, bringing total gross proceeds from the offering to approximately $13.8 million, before deducting underwriting discounts and commissions and other offering-related expenses. This exercise of the over allotment closed on

Oct 05, 2016 01:14 pm ET

VolitionRx Limited Announces Closing of Public Offering of Common Stock

NAMUR, Belgium, Oct. 5, 2016 /PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing diagnostic tests for cancer, today announced the closing of its previously announced underwritten public offering of 2.25 million shares of common stock at a public offering price of $5.00 per share. The net proceeds are expected to be approximately $10.6 million, after deducting underwriting discounts, commissions and estimated offering expenses payable by Volition. All of the shares in the offering were offered by Volition.

Sep 27, 2016 03:30 am ET

Nano Dimension Ltd. Raises $12M in Public Offering of American Depositary Shares

NESS ZIONA, Israel, Sept. 27, 2016 /PRNewswire/ -- Nano Dimension Ltd., a leader in the field of 3D Printed Electronics (NASDAQ, TASE: NNDM), today announced the pricing of its public offering of 1,850,000 American Depository Shares (ADSs) at a price of $6.50 per ADS. In addition, Nano Dimension has granted the underwriters a 45-day over-allotment option to purchase up to 277,500 additional ADSs at the public offering price. All of the ADSs are being offered by the Company.

Sep 21, 2016 12:00 pm ET

Capricor Therapeutics Announces Closing of Public Offerings Raising Approximately $10.0 Million in Net Proceeds

LOS ANGELES, Sept. 21, 2016 /PRNewswire/ -- Capricor Therapeutics, Inc. (NASDAQ: CAPR) today announced the closing of its previously announced underwritten registered public offering and concurrent registered direct offering. In the registered public offering, a total of 3,090,625 shares of the Company's common stock were sold at an offering price of $3.20 per share. The shares include 403,125 shares of common stock sold pursuant to the underwriters' over-allotment option, which option was exercised in full. In the registered direct offering, a total of 312,500 shares of the Company's common

Sep 12, 2016 08:30 am ET

Fortress Biotech Completes Tender Offer for Shares of National Holdings Corporation

NEW YORK, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress” or “FBIO”) and National Holdings Corporation (NASDAQ:NHLD) (“NHLD”) today announced that an affiliate of Fortress, FBIO Acquisition, Inc., has completed its previously announced tender offer (the “Offer”) to purchase all outstanding shares of NHLD for $3.25 per share, net to the seller in cash but subject to any required withholding of taxes....

Jun 21, 2016 12:00 pm ET

Tonix Pharmaceuticals Completes $10 Million Public Offering of Common Stock

NEW YORK, June 21, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), today announced the closing of its previously announced underwritten public offering of 5,000,000 shares of its common stock. The shares were sold at the public offering price of $2.00 per share, bringing the aggregate gross proceeds from the offering to $10 million, before deducting underwriting discounts and commissions and other offering expenses. The financing was led by healthcare focused institutional investors....

Jun 16, 2016 08:00 am ET

Tonix Pharmaceuticals Prices Underwritten Public Offering of Common Stock

NEW YORK, June 16, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a price of $2.00 per share. Tonix has also granted to the underwriters a 45-day option to acquire an additional 750,000 shares to cover overallotments in connection with the offering....

Jun 15, 2016 04:01 pm ET

Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock

NEW YORK, June 15, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), today announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering....

Jun 15, 2016 01:00 pm ET

Champions Oncology, Inc. Announces Closing of Public Offering of Common Stock

HACKENSACK, N.J., June 15, 2016 /PRNewswire/ -- Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the closing of its previously announced underwritten public offering of 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, the Company announced today the partial exercise of the over-allotment option granted to the underwriter to purchase

Jun 09, 2016 08:30 pm ET

Champions Oncology, Inc. Announces Pricing of Public Offering of Common Stock

HACKENSACK, N.J., June 9, 2016 /PRNewswire/ -- Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the pricing of its previously announced underwritten public offering. The Company is offering 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, Champions Oncology, Inc. has granted the underwriter a 45-day over-allotment option to purchase up to

May 19, 2016 08:30 am ET

Interstate Batteries and Aqua Metals Form Strategic Partnership

ALAMEDA, Calif., May 19, 2016 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ:AQMS) (Aqua Metals), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining™, today announced the signing of definitive agreements with Interstate Batteries. Interstate Batteries is the No. 1 replacement battery brand, the largest independent battery distribution system in North America and the country’s leading battery recycler....

Apr 28, 2016 08:50 am ET

Fortress Biotech and National Holdings Announce Agreement

National Holdings Corporation (NASDAQ: NHLD) ("National Holdings" or "NHLD"), a full-service investment banking and asset management firm, and Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress" or "FBIO"), a biopharmaceutical company dedicated...

You are here

(:NHLD)

Business Focus: N/A